PYPD Stock Analysis: Buy, Sell, or Hold?
PYPD - PolyPid Ltd. Ordinary Shares
$4.04
0.14 (3.46%)
▲
5d:
-21.65%
30d:
-11.71%
90d:
-12.66%
WAIT
LOW Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 12, 2026
15d
Get Alerted When PYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PYPD is down 21.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PYPD is down 21.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PYPD is currently trading at $4.04, which is considered oversold relative to its 30-day fair value range of $4.60 to $5.35.
Technical Outlook: Technically, PYPD is in a uptrend. Immediate support is located at $3.65, while resistance sits at $5.73. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+207.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PYPD is in a uptrend. Immediate support is located at $3.65, while resistance sits at $5.73. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+207.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.60 -
$5.35
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 207.7% below Wall St target ($12.00)
- WARNING: Recommendation downgraded due to -21.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$4.60 -
$5.35
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.65
Resistance Level
$5.73
Current Trend
Uptrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.50
Wall Street Target
$12.00
(+207.7%)
Share & Embed Analysis
Last updated: July 27, 2026 11:39 AM ET
Data refreshes hourly during market hours. Next update: 12:39 PM
Data refreshes hourly during market hours. Next update: 12:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$86 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 51 HOLD |
